PHARMACY LEADERS

Calvin Knowlton

Founder and CEO of Tabula Rasa Healthcare

A colorful astronaut holding a blue flag

About

For the past 30 years, Calvin Knowlton has used his experience in business, pharmacy, and technology to develop innovative products that change the way pharmacists dispense 一 and patients take 一 medication. As the Founder and CEO of Tabula Rasa Healthcare, Calvin creates tools designed to reduce medication-related risk. His proprietary technology, MedWise, identifies accumulative multi-drug interactions and eliminates complications. Other products, like CareKinesis, RxCompanion, and Medilance, also help pharmacists to reduce risk and get reimbursed for their services. Calvin has received a number of awards and holds important leadership positions in the world of healthcare technology. His career has been marked by his willingness to serve and innovate.
Organizations
  • APhA Pharmacogenomics Task Force - Member
  • National Pharmacogenomics Advisory Group - Member
  • Evergreens Continuing Care Retirement Community - Chair of the Board
  • Cooper Medical School of Rowan University - Board Member
  • University of the Sciences in Philadelphia - Former Professor and Department Chair
  • Coriell Institute for Medical Research - Former Board Member
  • St Christopher’s Hospital for Children in Philadelphia - Former Board Member
Notable Achievements
  • 2003, 2013 - Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region
  • 2004 - Walter M. Aikman Entrepreneur of the Year Award
  • 1997 - Most Influential U.S. Pharmacist Award
  • Authored/co-authored several textbooks and articles relating to medication care
Areas of Focus and Expertise
  • Healthcare Technology
  • Pharmacy Innovation
  • Entrepreneurship

About

For the past 30 years, Calvin Knowlton has used his experience in business, pharmacy, and technology to develop innovative products that change the way pharmacists dispense 一 and patients take 一 medication. As the Founder and CEO of Tabula Rasa Healthcare, Calvin creates tools designed to reduce medication-related risk. His proprietary technology, MedWise, identifies accumulative multi-drug interactions and eliminates complications. Other products, like CareKinesis, RxCompanion, and Medilance, also help pharmacists to reduce risk and get reimbursed for their services. Calvin has received a number of awards and holds important leadership positions in the world of healthcare technology. His career has been marked by his willingness to serve and innovate.
Organizations
  • APhA Pharmacogenomics Task Force - Member
  • National Pharmacogenomics Advisory Group - Member
  • Evergreens Continuing Care Retirement Community - Chair of the Board
  • Cooper Medical School of Rowan University - Board Member
  • University of the Sciences in Philadelphia - Former Professor and Department Chair
  • Coriell Institute for Medical Research - Former Board Member
  • St Christopher’s Hospital for Children in Philadelphia - Former Board Member
Notable Achievements
  • 2003, 2013 - Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region
  • 2004 - Walter M. Aikman Entrepreneur of the Year Award
  • 1997 - Most Influential U.S. Pharmacist Award
  • Authored/co-authored several textbooks and articles relating to medication care
Areas of Focus and Expertise
  • Healthcare Technology
  • Pharmacy Innovation
  • Entrepreneurship
Image of a blue divider

guest appearance ON

Podcast

Podcast

Episode
24

“Who Cares About Adherence?”

What’s the use of being perfectly adherent to a poor medication regimen? Before measuring adherence, it should first be confirmed that a patient is taking the right medications, at the right dose, at the right time. Factors like family genetics and drug interactions can affect the way a patient responds to their medications, and evaluating these factors is a valuable service that pharmacists can provide to their patients. Dr. Calvin Knowlton joins us to explain his mission behind MedWise and why this medication safety tool can help pharmacists use the skills they learned in school to save lives and improve their patients’ quality of life.
Patient Outcomes • Payment Model
Image of a blue divider